journal article·2025-12

A NIR-II AIE luminogen based nanoplatform with nitric oxide controlled release properties for NIR-II fluorescence guided combined photodynamic/photothermal/gas therapy

Siyu Zhang, Weiping Zhou, Wei Zhou, Ruohui Zhang, Shuang Song, Chang Liu, Ying Li, Di He, Mahmood Hassan Akhtar, Cong Yu

Dyes and Pigments· Volume 243
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. A near-infrared triggered multi-functional indocyanine green nanocomposite with NO gas release function inducing improved photothermal therapy10.1016/j.jcis.2024.10.071 ↗
2. Cationic conjugated polymer coupled non-conjugated segments for dually enhanced NIR-II fluorescence and lower-temperature photothermal-gas therapy10.1186/s12951-024-02741-9 ↗
3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
5. Cancer treatment therapies: traditional to modern approaches to combat cancers10.1007/s11033-023-08809-3 ↗
6. Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide combined cancer therapy10.1016/j.cej.2024.148618 ↗
7. Near-infrared-triggered Dibenzo[a,c][1,2,5]thiadiazolo[3,4-i]phenazine heterocyclic derivatives for type-I photodynamic and photothermal therapy against human nasopharyngeal carcinoma10.1016/j.dyepig.2024.112133 ↗
8. Nanostructured cruciform phototheranostic agents for efficient multimodal imaging-guided type I photodynamic/photothermal synergistic therapy10.1016/j.dyepig.2024.112283 ↗
9. Optimizing phototherapy efficiency via dynamic adjusting the contributions of photodynamic and photothermal therapy of diketopyrrolopyrrole-based compounds10.1016/j.dyepig.2024.112049 ↗
10. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
11. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation10.1038/s41467-023-38601-7 ↗
12. Advent in proteins, nucleic acids, and biological cell membranes functionalized nanocarriers to accomplish active or homologous tumor targeting for smart amalgamated chemotherapy/photo-therapy: a review
13. Light-triggered nitric oxide nanogenerator with high L-arginine loading for synergistic photodynamic/gas/photothermal therapy10.1002/adhm.202300012 ↗
14. An asymmetric NIR-II organic fluorophore with an ultra-large stokes shift for imaging-guided and targeted phototherapy10.1021/acsbiomaterials.4c00496 ↗
15. Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging10.1002/adma.202305668 ↗
16. Molecular engineering of NIR‐II/IIb emitting AIEgen for multimodal imaging-guided photo-immunotherapy10.1002/smll.202300859 ↗
17. Near-infrared II fluorescence imaging10.1038/s43586-024-00301-x ↗
18. Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: from near-infrared-I to near-infrared-II10.1016/j.jconrel.2023.08.056 ↗
19. NIR-II aggregation-induced emission luminogens for tumor phototheranostics10.3390/bios12010046 ↗
20. Regulating aggregation-induced emission luminogen for multimodal imaging-navigated synergistic therapy involving anti-angiogenesis10.1002/advs.202302713 ↗
21. BODIPY-based nanoparticles for highly efficient photothermal/gas synergistic therapy against drug-resistant bacterial infection10.1007/s10853-024-10351-x ↗
22. Gas therapy: generating, delivery, and biomedical applications10.1002/smtd.202301349 ↗
23. Photothermal/NO combination therapy from plasmonic hybrid nanotherapeutics against breast cancer10.1016/j.jconrel.2022.03.030 ↗
24. Recent advances on the development of NO-releasing molecules (NORMs) for biomedical applications10.1016/j.ejmech.2024.116217 ↗
25. Opportunities for nitric oxide in potentiating cancer immunotherapy10.1124/pharmrev.121.000500 ↗
26. The triple crown: NO, CO, and H2S in cancer cell biology10.1016/j.pharmthera.2023.108502 ↗
27. Nitric oxide: physiological functions, delivery, and biomedical applications10.1002/advs.202303259 ↗
28. Current advances of nitric oxide in cancer and anticancer therapeutics10.3390/vaccines9020094 ↗
29. Insights on the functional dualism of nitric oxide in the hallmarks of cancer10.1016/j.bbcan.2023.189001 ↗
30. Doxorubicin hydrochloride and L-arginine co-loaded nanovesicle for drug resistance reversal stimulated by near-infrared light
31. Emerging nitric oxide gas-assisted cancer photothermal treatment
32. Nitric oxide-photodelivering materials with multiple functionalities: from rational design to therapeutic applications10.1021/acsami.4c13478 ↗
33. Customized A-D-A type molecule to construct a nitric oxide nanogenerator with enhanced antibacterial activity for infected wound healing10.1039/D4TB01201A ↗
34. NIR-II AIEgens: a win-win integration towards bioapplications10.1002/anie.202005899 ↗
35. Precise molecular design for high-performance luminogens with aggregation-induced emission10.1002/adma.201903530 ↗
36. Biologically excretable aggregation-induced emission dots for visualizing through the marmosets intravitally: horizons in future clinical nanomedicine10.1002/adma.202008123 ↗
37. BF2-bridged azafulvene dimer-based 1064 nm laser-driven superior photothermal agent for deep-seated tumor therapy10.1002/anie.202407307 ↗
38. Promoted NIR-II fluorescence by heteroatom-inserted rigid-planar cores for monitoring cell therapy of acute lung injury
39. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
40. Near-infrared II agent with excellent overall performance for imaging-guided photothermal thrombolysis10.1021/acsnano.4c06965 ↗
41. An active self-mitochondria-targeting cyanine immunomodulator for near-infrared II fluorescence imaging-guided synergistic photodynamic immunotherapy10.1002/adhm.202401061 ↗
42. Integration of motion and stillness: a paradigm shift in constructing nearly planar NIR-II AIEgen with ultrahigh molar absorptivity and photothermal effect for multimodal phototheranostics10.1021/jacs.4c15216 ↗
43. Toward type I/II ROS generation photoimmunotherapy by molecular engineering of semiconducting perylene diimide10.1002/adhm.202303175 ↗
44. BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy10.1016/j.bios.2023.115895 ↗
45. Photo‐triggered cascade therapy: a NIR-II AIE luminogen collaborating with nitric oxide facilitates efficient collagen depletion for boosting pancreatic cancer phototheranostics10.1002/adma.202306476 ↗
46. Nitric-oxide-enhanced positively charged semiconductor conjugated polymer composite nanomaterials for antibiofilm in vivo10.1002/adfm.202415134 ↗
47. Light-activated nitric-oxide overproduction theranostic nanoplatform based on long-circulating biomimetic nanoerythrocyte for enhanced cancer gas therapy10.1007/s11426-021-1045-9 ↗
48. Acceptor-donor-acceptor-type molecules with large electrostatic potential difference for effective NIR photothermal therapy10.1039/D4TB00187G ↗
49. Supramolecular prodrug-like nanotheranostics with dynamic and activatable nature for synergistic photothermal immunotherapy of metastatic cancer10.1016/j.jconrel.2024.01.052 ↗
50. Near-infrared-II fluorophore with inverted dependence of fluorescence quantum yield on polarity as potent phototheranostics for fluorescence-image-guided phototherapy of tumors10.1002/adma.202209647 ↗
51. As aggregation-induced emission meets with noncovalent conformational locks: subtly regulating NIR-II molecules for multimodal imaging-navigated synergistic therapies
52. NIR-II absorbing conjugated polymer nanotheranostics for thermal initiated NO enhanced photothermal therapy10.3390/bios13060642 ↗
53. Zwitterionic AIEgens: rational molecular design for NIR-II fluorescence imaging-guided synergistic phototherapy10.1002/adfm.202007026 ↗
54. Selenium-integrated conjugated oligomer nanoparticles with high photothermal conversion efficiency for NIR-II imaging-guided cancer phototheranostics in vivo10.1186/s12951-023-02080-1 ↗
55. Phototheranostic agents based on nonionic heptamethine cyanine for realizing synergistic cancer phototherapy10.1002/adhm.202202817 ↗
56. Atomic-iodine-substituted polydiacetylene nanospheres with boosted intersystem crossing and nonradiative transition through complete radiative transition blockade for ultraeffective phototherapy10.1002/agt2.576 ↗